RFA #20620: Expanding Harm Reduction Services for Priority Populations Who Use Drugs - Reissue

The New York State Department of Health AIDS Institute, Office of Drug User Health announces the availability of New York State funds to provide harm reduction interventions in community settings in New York State. This funding is directed toward people who use drugs within two (2) distinct Priority Populations* (Adolescents (12-17)/Young Adults (18-24) and Veterans) that are especially vulnerable to overdose and who have been historically marginalized and stigmatized by systems of care. Advancing health equity is an expected outcome of this Request for Applications and the programs awarded funding. The intent of the Request for Applications is to fund two (2) to four (4) programs for awards between $200,000 to $300,000, with a total funding amount of $1,200,000 annually from November 1, 2025, through June 30, 2028.

*For purposes of this Request for Applications (RFA) Priority Populations of focus are defined as Adolescents (12-17)/Young Adults (18-24) and Veterans.

This Request for Applications (RFA) has been posted on the following websites:

The NYS Statewide Financial System (SFS) website at: Search for Grant Opportunities (ny.gov)

Search using the SFS # in the Event ID field: Pops2025

New York State Department of Health: http://www.health.ny.gov/funding/

In order to apply for this Request for Applications, eligible applicants must be prequalified in the Statewide Financial System and must submit an application via the Statewide Financial System.

Applicants may submit no more than two (2) applications in response to the Request for Applications. Applicants may submit no more than one (1) application per Priority Population.

Late applications will not be accepted.

Applications will not be accepted via fax, e-mail, hard copy or hand delivery.

KEY DATES

RFA Release Date: March 27, 2025

Questions Due: April 10, 2025, by 4:00 PM ET

Questions, Answers and

Updates Posted: (on or about) April 24, 2025

Applications Due: May 14, 2025, by 4:00 PM ET

DOH Contact Name & Address:

Elizabeth Girolami

Office of Drug User Health

New York State Department of Health/AIDS Institute

Email: PriorityPopsRFA@health.ny.gov

All substantive questions by Applicants with respect to any aspect of the RFA must be submitted in writing to Elizabeth Girolami, NYSDOH AIDS Institute, Office of Drug User Health, at the following email address: PriorityPopsRFA@health.ny.gov . This includes Minority and Women Owned Business Enterprise (M/WBE) questions and questions pertaining to the M/WBE forms. See, Section IV. K. (Minority & Women-Owned Business Enterprise (M/WBE) Requirements). Questions of a technical nature related to formatting or other minor details related to preparation of an Application may also be addressed in writing to the email address noted above. Questions are of a technical nature if they are limited to how to prepare your Application (e.g., formatting) rather than relating to the substance of the Application.

To the degree possible, each question submitted by a potential Applicant pursuant to the terms of this RFA should cite the RFA section and paragraph to which it refers. Written questions will be accepted until the date posted on the Cover Page of the RFA. All questions submitted should state the RFA Title and Number set forth on the Cover Page (RFA #20620: Expanding Harm Reduction Services for Priority Populations Who Use Drugs – Reissue) in the subject line of the email.